|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on May 14, 2014 |
Title |
Guselkumab (interleukin-23-specific monoclonal antibody) demonstrates clinical and molecular response in moderate-to-severe psoriasis |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
A gene expression profiling study was conducted in which skin biopsy samples were collected for RNA extraction and hybridization to microarrays from patients with moderate-to-severe psoriasis who participated in the phase 1, guselkumab first-in-human randomized, double-blind, placebo-controlled trial. At week 12, significant reductions in psoriasis gene expression were observed in guselkumab-treated patients.
|
|
|
Overall design |
Skin biopsy samples (n=59, LS: lesion, NL: non-lesion) were collected at baseline, weeks 1 and 12 following guselkumab treatment from patients with moderate-to-severe psoriasis for RNA extraction and microarray analysis.
|
|
|
Contributor(s) |
Sofen H, Smith S, Matheson RT, Leonardi CL, Calderon C, Brodmerkel C, Li K, Campbell K, Marciniak SJ Jr, Wasfi Y, Wang Y, Szapary P, Krueger JG |
Citation(s) |
24679469, 37071038 |
|
Submission date |
Oct 18, 2013 |
Last update date |
Nov 09, 2023 |
Contact name |
K Li |
E-mail(s) |
[email protected]
|
Organization name |
Janssen R&D
|
Street address |
1400 McKean Road
|
City |
Spring House |
State/province |
PA |
ZIP/Postal code |
19477 |
Country |
USA |
|
|
Platforms (1) |
GPL13158 |
[HT_HG-U133_Plus_PM] Affymetrix HT HG-U133+ PM Array Plate |
|
Samples (59)
|
|
Relations |
BioProject |
PRJNA223228 |
Supplementary file |
Size |
Download |
File type/resource |
GSE51440_RAW.tar |
117.6 Mb |
(http)(custom) |
TAR (of CEL) |
Processed data included within Sample table |
|
|
|
|
|